Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 4
2008 2
2009 2
2010 1
2011 3
2012 4
2013 3
2014 7
2015 9
2016 11
2017 23
2018 26
2019 22
2020 22
2021 25
2022 25
2023 28
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

195 results

Results by year

Filters applied: . Clear all
Page 1
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma.
Rodriguez-Otero P, Ailawadhi S, Arnulf B, Patel K, Cavo M, Nooka AK, Manier S, Callander N, Costa LJ, Vij R, Bahlis NJ, Moreau P, Solomon SR, Delforge M, Berdeja J, Truppel-Hartmann A, Yang Z, Favre-Kontula L, Wu F, Piasecki J, Cook M, Giralt S. Rodriguez-Otero P, et al. Among authors: ailawadhi s. N Engl J Med. 2023 Mar 16;388(11):1002-1014. doi: 10.1056/NEJMoa2213614. Epub 2023 Feb 10. N Engl J Med. 2023. PMID: 36762851 Clinical Trial.
Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update.
Muchtar E, Dispenzieri A, Gertz MA, Kumar SK, Buadi FK, Leung N, Lacy MQ, Dingli D, Ailawadhi S, Bergsagel PL, Fonseca R, Hayman SR, Kapoor P, Grogan M, Abou Ezzeddine OF, Rosenthal JL, Mauermann M, Siddiqui M, Gonsalves WI, Kourelis TV, Larsen JT, Reeder CB, Warsame R, Go RS, Murray DL, McPhail ED, Dasari S, Jevremovic D, Kyle RA, Lin Y, Lust JA, Russell SJ, Hwa YL, Fonder AL, Hobbs MA, Rajkumar SV, Roy V, Sher T. Muchtar E, et al. Among authors: ailawadhi s. Mayo Clin Proc. 2021 Jun;96(6):1546-1577. doi: 10.1016/j.mayocp.2021.03.012. Mayo Clin Proc. 2021. PMID: 34088417 Review.
The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma.
Rejeski K, Hansen DK, Bansal R, Sesques P, Ailawadhi S, Logue JM, Bräunlein E, Cordas Dos Santos DM, Freeman CL, Alsina M, Theurich S, Wang Y, Krackhardt AM, Locke FL, Bachy E, Jain MD, Lin Y, Subklewe M. Rejeski K, et al. Among authors: ailawadhi s. J Hematol Oncol. 2023 Jul 31;16(1):88. doi: 10.1186/s13045-023-01465-x. J Hematol Oncol. 2023. PMID: 37525244 Free PMC article.
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.
Moreau P, Chari A, Oriol A, Martinez-Lopez J, Haenel M, Touzeau C, Ailawadhi S, Besemer B, de la Rubia Comos J, Encinas C, Mateos MV, Salwender H, Rodriguez-Otero P, Hulin C, Karlin L, Sureda Balari A, Bargay J, Benboubker L, Rosiñol L, Tarantolo S, Terebelo H, Yang S, Wang J, Nnane I, Qi M, Kosh M, Delioukina M, Goldschmidt H. Moreau P, et al. Among authors: ailawadhi s. Blood Cancer J. 2023 Mar 7;13(1):33. doi: 10.1038/s41408-023-00805-x. Blood Cancer J. 2023. PMID: 36882409 Free PMC article. No abstract available.
Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma.
Bansal R, Baksh M, Larsen JT, Hathcock MA, Dingli D, Stewart AK, Kapoor P, Kourelis T, Hayman SR, Warsame RM, Fonseca R, Bergsagel PL, Ailawadhi S, Kumar SK, Lin Y. Bansal R, et al. Among authors: ailawadhi s. Blood Cancer J. 2023 Apr 5;13(1):47. doi: 10.1038/s41408-023-00820-y. Blood Cancer J. 2023. PMID: 37019896 Free PMC article.
Cardiac Myeloid Sarcoma: Review of Literature.
Gautam A, Jalali GK, Sahu KK, Deo P, Ailawadhi S. Gautam A, et al. Among authors: ailawadhi s. J Clin Diagn Res. 2017 Mar;11(3):XE01-XE04. doi: 10.7860/JCDR/2017/23241.9499. Epub 2017 Mar 1. J Clin Diagn Res. 2017. PMID: 28511492 Free PMC article. Review.
Many Shades of Disparities in Myeloma Care.
Ganguly S, Mailankody S, Ailawadhi S. Ganguly S, et al. Among authors: ailawadhi s. Am Soc Clin Oncol Educ Book. 2019 Jan;39:519-529. doi: 10.1200/EDBK_238551. Epub 2019 May 17. Am Soc Clin Oncol Educ Book. 2019. PMID: 31099639 Free article. Review.
Novel therapeutic targets in Waldenstrom macroglobulinemia.
Paulus A, Ailawadhi S, Chanan-Khan A. Paulus A, et al. Among authors: ailawadhi s. Best Pract Res Clin Haematol. 2016 Jun;29(2):216-228. doi: 10.1016/j.beha.2016.08.020. Epub 2016 Sep 7. Best Pract Res Clin Haematol. 2016. PMID: 27825468 Review.
Multiple Myeloma: Current Clinical Landscape and Compounding Costs.
Beck K, Sandahl T, Ailawadhi S, Khera N, Jensen C. Beck K, et al. Among authors: ailawadhi s. Curr Hematol Malig Rep. 2023 Oct;18(5):201-215. doi: 10.1007/s11899-023-00705-8. Epub 2023 Jul 21. Curr Hematol Malig Rep. 2023. PMID: 37477783 Review.
195 results